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1  |  INTRODUC TION
Taste or olfactory disorders have been reported to occur in a third of 
patients in the early stages of COVID-19, the SARS-CoV-2 infections 
(Cevik et al., 2020; Zhang et al., 2020a, 2020b) (International 
Committee on Taxonomy of Viruses). With the infection, there 
are patients who suddenly notice taste disorders antecedent to 
other infection symptoms. In SARS-CoV-2 the viral genomic RNA 
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Abstract
The distribution of cells expressing SARS-CoV-2 entry factor angiotensin-converting 
enzyme 2 (ACE2) and transmembrane serine protease 2 (TMPRSS2) in human oral tis-
sues were tested. The investigation was conducted with normal flesh tissue and par-
affin-embedded specimens. The ACE2 and TMPRSS2 expression was detected with 
all subjects in the normal mucosa of the keratinized stratified squamous epithelia of 
the tongue and non-keratinized stratified squamous epithelia of the lip and cheek. It 
was found that ACE2 is expressed in the cytoplasm and on the cell membrane mainly 
in the stratum granulosum of the epithelia while the TMPRSS2 is strongly expressed 
on the cell membrane mainly in the stratum granulosum and stratum spinosum, but 
not in the stratum basale. Antibodies’ reactions for ACE2 and TMPRSS2 were not 
observed in the nuclei or keratin layer. The expression of ACE2 and TMPRSS2 in the 
oral epithelia appears to be general, and the expression was also observed in the 
mucous and serous acini of the labial glands. The SARS-CoV-2 may transiently attach 
to the oral mucosa and the minor salivary glands which are present under all of the 
oral mucosa. The oral cavity can be considered an important organ for SARS-CoV-2 
attachment and may provide a preventive medical avenue to guard against COVID-19 
by preventing saliva from scattering.
K E Y W O R D S
oral tissues, SARS-CoV-2
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is surrounded by an envelope consisting of a lipid bilayer and outer 
membrane proteins. The SARS-CoV-2 initiates entry into human 
cells after the Spike protein (S) on the envelope binds to the SARS-
CoV-2 entry factor angiotensin-converting enzyme 2 (ACE2) which 
is a metallopeptidase on the cell membrane. The Spike is cleaved 
into S1 and S2 by a host cell-derived protease assumed to be Furin. 
The S1 binds to ACE2 and S2 is cleaved by another SARS-CoV-2 
entry factor, a host cell-derived transmembrane serine protease 2 
(TMPRSS2) and membrane fusion proceeds as a result of this. The 
ACE2 and TMPRSS2 are critical factors in the airway infection for 
SARS-CoV-2 (Sungnak et al., 2020). There are reports that saliva is 
a source of SARS-CoV-2 infection, suggesting that oral tissue in-
cluding the salivary glands play a role as an organ for viral multipli-
cation in an inapparent infection by SARS-CoV-2 (Azzi et al., 2020; 
Xu et al., 2020a, 2020b) but the presence of the virus receptor has 
not been shown here. There has also been a detailed report on the 
rat sialodacryoadenitis virus which is a corona virus infection of 
the salivary gland (Jacoby et al., 2006). There have been immuno-
histochemical reports on ACE2 and TMPRSS2 in the oral mucosa, 
which appear to include reactions to nuclei and keratin (Bertram 
et al., 2012; Sakaguchi et al., 2020). The expression of ACE2 in oral 
tissue was reported by a study using the public RNA database (Xu 
et al., 2020a).
A number of human viral infections of the oral keratinized strat-
ified squamous epithelia are known. Coxsackievirus and adenovirus 
infect via their receptor in the tight junction of the stratified squa-
mous epithelia (Slots, 2000). Papillomavirus infects the basal cells 
of the stratified squamous epithelia via wounding or micro trauma 
(Syrjänen, 2018). Here the virions are produced in the surface of 
the epithelium and spread into the surrounding tissue, and the viral 
genome remains as a plasmid in the basal cell nuclei. The produc-
tion of viral proteins is controlled by differentiation and movement 
of the infected cells to the mucous surface. Herpes simplex virus 
type1 infects Langerhans cells and spreads to the oral mucosa from 
apoptotic Langerhans cells, and the oral cavity is the most import-
ant organ for widespread shedding of the virion (Lynch, 2000). The 
possibility of SARS-CoV2 proliferation in oral stratified squamous 
epithelia is still unknown but it may be speculated that virions could 
attach transiently. The present study aimed to provide details of the 
distribution of cells expressing the SARS-CoV-2 entry factors ACE2 
and TMPRSS2 in the cytoplasm and cell membrane in oral tissue at 
immunohistochemical detection levels.
2  |  MATERIAL S AND METHODS
2.1  |  Ethics
The protocol of the experiments for animal use was approved by 
the Animal Experiment Committee of Fukuoka Dental College (no. 
19010). The study for human tissue specimens was approved by in-
stitutional review boards of Tokyo Medical and Dental University 
(No. D2015-600-03) and Okayama University (2005-004). The 
human study was conducted with written informed consent. All 
methods were performed in accordance with the relevant guidelines 
and regulations.
2.2  |  Mouse subjects
An animal study was conducted to establish the distribution 
of cells expressing ACE2 and TMPRSS2 immunohistochemi-
cally. The experimental procedures were prepared following the 
ARRIVE guidelines. All applicable international, national, and/
or institutional guidelines for the care and use of animals were 
followed. All procedures performed in the studies were in ac-
cordance with the ethical standards of the institutional and/or 
national research committee and with the 1964 Helsinki declara-
tion and its later amendments or comparable ethical standards. 
All methods were performed in accordance with the relevant 
guidelines and regulations. We used 4-week-old male mice 
(C57BL/6, n = 5) purchased from a commercial vendor (Kyudo, 
Fukuoka, Japan). Keeping and experiments were performed in a 
room with a 100% controlled atmosphere which had passed an 
examination for bacteria and is located in the Fukuoka Dental 
College Animal Center. Mice were kept healthily under conven-
tional atmosphere conditions with normal feeding in cages. The 
mice were housed with an inverse 12-h day-night cycle with 
lights on from 7:00 pm in a room where the temperature (22°C) 
and humidity (55%) were strictly controlled. Immediately after 
the purchase all the specimens were collected from mice eutha-
nized by induction anesthesia (1 l/min of 2% isoflurane mixed 
with 30% oxygen and 70% nitrous oxide with an anaesthetic 
apparatus) followed by intraperitoneal injections with sodium 
pentobarbital (150 mg/kg, Sumitomo Dainippon Pharma Co., 
Ltd.) and cervical dislocation.
2.3  |  Human subjects
The investigation was conducted for normal human specimens: oral 
cells collected by swabs from volunteers including the corresponding 
author (n = 8); oral tissue was surgically dissected from the tongue 
and cheek of one volunteer (corresponding author); the tissue, was 
stored at −80°C in a deep freezer, and was surgically removed from 
patients as well as donations for dissection training were obtained 
with informed consent. Investigation was also conducted on stored 
paraffin embedded sections of normal human lip and tongue tissue 
in samples surgically resected due to cysts and cancer from 20 pa-
tients (aged 24–84 years).
2.4  |  Cells
Human epithelial-like cell lines of oral squamous cell carcinoma 
HSC2/RCB1945, tongue squamous cell carcinoma HSC3/RCB1975, 
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and tongue squamous cell carcinoma HSC4/RCB1902 were pur-
chased from the Institute of Physical and Chemical Research 
BioResource Research Center (RIKEN, Tsukuba, Japan). The human 
glioma cell line LN319 was purchased from Addexbio Technologies. 
All cells were maintained in minimum essential medium eagle, alpha 
modification (Sigma-Aldrich Co. LLC.) with 10% serum.




007393 Actb GTTCTACAAATGTGGCTGAGGA 411
59ATTGGTCTCAAGTCAGTGTACAG










015775 Tmprss2 GTTACTTTGAAGAATGGGATCTGGTG 141
58GCTGTTCGCCCTCATTTGCT
001135099 TMPRSS2, transcript variant 1a  CGGCAGGTCATATTGAACATTCCA 318
59ACAGTGCTTTCTTAGTCTTTGAGGTG
Gene symbols are described according to international notation.
aPrimer sequences for genes with variants were designed in the region common to variants. 
F I G U R E  1  RT-PCR analysis for mouse tissue. The RT-PCR analysis for the mouse tissue shows that there are cells expressing ACE2 and 
TMPRSS2 in the submandibular gland, tongue, small intestine, and kidney. The real time-PCR analysis shows that the gene expression of 
ACE2 in the small intestine and TMPRSS2 in the kidney was significantly stronger than in other tissues. Target gene cDNA were normalized 
to β-actin cDNA. The relative gene expression was expressed as arbitrary units according to the following formula: cDNA amounts of 
experimental samples/cDNA amounts of samples determined as controls (ACE2: kidney, TMPRSS2: small intestine). Values are means ± SD. 
*Significantly different in ANOVA (p < 0.01)
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2.5  |  PCR sampling
Normal tissue of the lingual mucosa from the volunteer, and 
mouse tissues of the submandibular gland, tongue, small intes-
tine, and kidney were used after the collection according to the 
method described above. Immediately after excision 5 mm square 
tissue specimens were ground into a paste with a scalpel on a 
glass plate in ice and dissolved in the RLT buffer of an RNeasy kit 
(Qiagen, Inc.). We also used squamous cell carcinoma cell lines 
HSC2, HSC3, and HSC4. The cells were dissolved in RLT buffer 
at the 80% confluence in one well of a 6-well plate. Furthermore, 
the buccal mucous epithelial total RNA was collected from vol-
unteers. Immediately after grinding a swab (Jonson's cotton bud 
was best; Jonson & Jonson K.K., Tokyo, Japan) against the volun-
teer's buccal mucosa eight times at places facing the tongue, the 
swab was immersed and spun in the RLT buffer of a RNeasy kit 
(Qiagen) in a 1.5 ml Eppendorf tube on ice, and the swab, swollen 
with solution was strongly squeezed by sterilized tweezers. The 
total RNA extraction from tissue and cells was assayed with a 
QIAshredder column and an RNeasy kit (Qiagen). Contaminating 
genomic DNA was removed using DNAfree (Ambion) only when 
many non-specific bands were found on the gel electrophoresis 
after PCR.
2.6  |  Microarray
A microarray was used for the HSC3 and LN319. The analysis was 
outsourced to Cell Innovator Inc. (Fukuoka, Japan). The analysis 
was performed by 50,600 probes integrated with the human ge-
nome DNA microarray 4x44 K v2 (Agilent Technologies Japan, 
Ltd.).
F I G U R E  2  RT-PCR analysis for human tissue and cells. The RT-PCR analysis for the human tissue of the lingual mucosa and buccal 
mucosa including normal keratinocytes shows that there are cells expressing ACE2 and TMPRSS2. In human epithelial-like oral cancer cell 
lines, the reaction product of RT-PCR for ACE2 mRNA was detected in HSC3 but not in HSC2 or HSC4. The reaction product for TMPRSS2 
mRNA was detected in HSC4 but not in HSC2 or HSC4. In the human glioma cell line LN319, the reaction product for ACE2 mRNA was not 
detected while the reaction product for TMPRSS2 mRNA was detected. The real time-PCR analysis shows that a strong expression of ACE2 
and TMPRSS2 genes are present in the lingual and buccal mucosa, and the gene expression of both ACE2 and TMPRSS2 was significantly 
stronger in the lingual mucosa than in buccal mucosa or cell line controls. Target gene cDNA were normalized to β-actin cDNA. The relative 
gene expression was expressed as arbitrary units according to the following formula: cDNA amounts of experimental samples/cDNA 
amounts of samples determined as controls (ACE2: HSC3, TMPRSS2: LN319). Values are means ± SD of 5 data. *Significantly different in 
ANOVA (p < 0.01)
    |  5SAWA et Al.
2.7  |  Real-time PCR
Reverse transcription was performed on 30 ng of total RNA, fol-
lowed by 38 cycles (annealin: 55–60°C) of PCR for amplifica-
tion using the Ex Taq hot start version (Takara Bio Inc.) with 
50 pM of primer sets (Table 1) where the specificities had been 
confirmed by the manufacturer (Thermo Fisher Scientific). The 
annealing temperature was varied between 55 and 60°C ac-
cording to the status of the RNA yield and DNA contamination 
a large number of times. The RT-PCR products were separated 
on 2% agarose gel (NuSieve; FMC), visualized by Syber Green 
(Takara), and the amplified PCR product size was confirmed by 
gel electrophoresis.
To quantify the mRNA generation, cDNA samples were analyzed 
by real-time quantitative PCR. A total of 1 μl of cDNA was amplified 
in a 25-μl volume of PowerSYBR Green PCR Master Mix (Applied 
Biosystems) in a Stratagene Mx3000P real-time PCR system 
(Agilent Technologies, Inc.), and the fluorescence was monitored at 
each cycle. Cycle parameters were 95°C for 15 min to activate Taq 
followed by 40 cycles of 95°C for 15 s, 58°C for 1 min, and 72°C for 
1 min. For the real-time analysis, two standard curves were created 
from amplicons for both the β-actin and target genes in three serial 
fourfold dilutions of cDNA. The β-actin or target gene cDNA lev-
els in each sample was quantified against β-actin or the target gene 
standard curves by allowing the Mx3000P software to accurately 
determine each cDNA unit. Finally, target gene cDNA units in each 
sample were normalized to β-actin cDNA units. Relative target gene 
expression units were expressed as arbitrary units, calculated ac-
cording to the following formula: relative experimental gene expres-
sion units =cDNA amounts of experimental samples/cDNA amounts 
of samples determined as controls. All experiments were repeated 
at least five times.
2.8  |  Immunostaining
For the cancer tissue specimens, 2-µm thick paraffin-embedded 
sections mounted on 3-aminopropyltriethoxysilane-coated 
F I G U R E  3  Immunostaining for ACE2 and TMPRSS2 of the mouse kidney and small intestine. HE staining (left panels) and immunostaining 
(right panels) for ACE2 (red), and for podoplanin (green) with DAPI staining of nuclei (blue). In the mouse kidneys (top panels), the reaction 
with anti-ACE2 (arrowheads) was only observed in the proximal tubular cells with brush border (HE), but no other region including the distal 
tubular cells (HE, arrows) reacted with anti-ACE2. It is possible to discriminate glomeruli stained with anti-podoplanin. In the sections of 
mouse small intestine (bottom panels), the reaction with anti-TMPRSS2 (red, arrowheads) was only observed in the monolayered columnar 
epithelial cells of the small intestine (HE), but no other region including the lamina propria mucosae (HE, arrows) reacted with anti-TMPRSS2. 
Bar: 100 μm
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slides were used. The sections were deparaffinized in changes 
of xylene, rehydrated in decreasing concentrations of ethanol, 
and rinsed with deionized distilled water for 10 min. The slides 
were immersed in 10 mM sodium citrate buffer (pH 6.0) or 
Envision Flex Target Retrieval Solution (Agilent Technologies, 
Inc.), and boiled in a microwave oven for 10 min to break 
formalin-formed protein cross-links masking the antigen. 
Immunohistochemistry was performed using the avidin-biotin 
peroxidase complex technique. After the boiling, the sections 
were rinsed by 10 mM PBS and then immersed for 10 min in 
methanol containing 3% hydrogen peroxide, followed by incu-
bation in 0.1% horse serum for 30 min at room temperature. 
The sections were then incubated with a rabbit anti-TMPRSS2 
(0.5 µg/ml, Abcam Inc., ab92323) and anti-ACE2 (Abcam, 
ab15348) diluted into the blocking solution for 8 h at 4°C. 
After the treatment with primary antibodies the sections were 
washed three times in PBS for 10 min and immunostained 
with a horse anti- rabbit IgG (0.5 μg/ml, Vector-Elite ABC kit; 
Vector Laboratories, Inc.) for 1 h at RT, and then visualized by 
a Vector VIP substrate kit (Vector) at RT.
Normal human 5–10 mm square tissue specimens of the 
lingual, labial, and buccal mucosa were obtained from the vol-
unteer by excision with a scalpel under infiltration anesthesia 
from in the author's laboratory. Mouse tissue of the tongue, 
small intestine, and kidney were collected after euthanasia by 
induction anesthesia of the mice with 2% isoflurane (1 l/min) 
and intraperitoneal injections with sodium pentobarbital (10 ml/
kg, Nembutal, Abbott Laboratories). Immediately after exci-
sion of tissue, cryo-embedding in Tissue-Tek Cryomold (Sakura 
Finetek Japan Co., Ltd.) was performed by using liquid nitrogen. 
The frozen 10 μm sections cut in a cryostat on slide glass were 
fixed in 100% methanol for 5 min at −20°C. The sections were 
treated with PBS blocking solution containing 0.1% goat serum 
for 30 min at 20°C and then with a 1 µg/ml rabbit anti-TMPRSS2 
(Abcam) and anti-ACE2 (Abcam) diluted into the blocking solu-
tion for 8 h at 4°C. Double immunostaining was performed on 
F I G U R E  4  Immunostaining for ACE2 and TMPRSS2 of the body of the mouse tongue. HE staining (left panels) and immunostaining (right 
panels) for ACE2 (upper right panel, red) and TMPRSS2 (lower right panel, red) with DAPI staining of nuclei (blue). Reactions with anti-ACE2 
and anti-TMPRSS2 are observed in the keratinized stratified squamous epithelia, containing filiform papilla (FP), but rarely in the cornified 
layer of the dorsal surface. Reactions with anti-ACE2 and anti-TMPRSS2 are observed in the circumvallate papilla (CP). Reactions with 
anti-ACE2 and anti-TMPRSS2 are observed in the pale barrel-shaped taste buds (arrowheads) of the lateral walls of the furrow encircled 
circumvallate papilla. Furthermore, reactions with anti-ACE2 and anti-TMPRSS2 can be observed in the serous acini of the von Ebner 
glands (EG) which have duct orifices (DO) connected to the bottom of the furrow. There is reaction with anti-ACE2 in the blood vessels 
in the intrinsic lingual muscle but not in the connective tissue of the lamina propria (LP). There is also reaction with anti-TMPRSS2 in the 
perimysium of the intrinsic lingual muscle and in the connective tissue of the lamina propria (LP). Bar: 100 μm
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only the mouse kidney sections with anti-ACE2 (Abcam) and a 
1 µg/ml hamster anti-podoplanin (Biolegend, Inc.) to distinguish 
renal glomerular podocytes. After the treatment with primary 
antibodies the sections were washed three times in PBS for 
10 min and immunostained for 1 h at 20°C with 0.1 μg/ml of 
Alexa Fluor 488-conjugated anti-hamster IgG and Alexa Fluor 
568-conjugated goat anti-hamster IgG (Probes Invitrogen Com.). 
The immunostained sections were mounted in 50% polyvin-
ylpyrrolidone solution and examined by microscope digital cam-
era systems with a CFI Plan Apo Lambda lens series and DS-Ri2/
Qi2 (Nikon Corp.). All experiments were repeated a number of 
times (5–10) with several sections.
2.9  |  Statistics
All experiments were repeated five times, and the data expressed as 
mean ±SD. Statistically significant differences (p < 0.01) were deter-
mined by one-way ANOVA and the unpaired two-tailed Student's t 
test with STATVIEW 4.51 software (Abacus Concepts).
3  |  RESULTS
3.1  |  RT-PCR analysis
The mouse tissue specimens from the kidney, small intestine, 
tongue, and submandibular gland showed expression of the 
ACE2 and TMPRSS2 genes (Figure 1). The gene expression of 
ACE2 in the small intestine and TMPRSS2 in the kidney was 
significantly stronger than in other tissues. In the microarray 
there was a HSC3 strain with the ACE2 gene expression and a 
LN319 strain with the TMPRSS2 gene expression (not shown). 
Therefore, these strains were used as experimental controls in 
the RT-PCR analysis of the human tissue. It was observed that in 
the human epithelial-like oral squamous cell carcinoma cell lines 
HSC2, HSC3, and HSC4 gene expression of ACE2 was present 
in HSC3 while the gene expression of TMPRSS2 was present in 
HSC4. The LN319 showed that ACE2 was absent but confirmed 
the presence of TMPRSS2. The normal human specimens from 
the lingual and buccal mucosa also showed a strong expression 
of ACE2 and TMPRSS2 (Figure 2). The gene expression of both 
F I G U R E  5  Immunostaining for ACE2 and TMPRSS2 of the root of the mouse tongue sections. HE staining (left panels) and 
immunostaining (right panels) for ACE2 (upper right panel, red) and TMPRSS2 (lower right panel, red) with DAPI staining of nuclei (blue). 
Reactions with anti-ACE2 and anti-TMPRSS2 are observed in the keratinized stratified squamous epithelia. Reactions with anti-ACE2 and 
anti-TMPRSS22 are observed in the mucous acini of the posterior lingual gland (arrowheads) with the duct also expressing both molecules 
(arrows). Reaction with anti-ACE2 is absent in the lingual muscle (LM) but weakly observed in the blood vessels of the lamina propria (LP). 
Reaction with anti-TMPRSS2 is absent in the lingual muscle but weakly present in the perimysium and in the lamina propria. Bar: 100 μm
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ACE2 and TMPRSS2 was significantly larger in the lingual mucosa 
than in other specimens.
3.2  |  Immunostaining of the mouse tissue
In the kidneys the reaction with anti-ACE2 was only observed in 
the proximal tubular cells with brush border and not in other re-
gions including not in glomeruli and distal tubular cells reacted with 
anti-ACE2 (Figure 3). In the small intestine the reaction with anti-
TMPRSS2 was only observed in monolayered columnar epithelial 
cells but not in other regions (Figure 3). Therefore, the tissue was 
used as experimental controls of RT-PCR analysis for the mouse tis-
sue. The expression of both ACE2 and TMPRSS2 was present on the 
keratinized stratified squamous epithelia but was rare in the corni-
fied layer of the dorsal surface of the tongue (Figure 4). The expres-
sion of both ACE2 and TMPRSS2 was present on the circumvallate 
papilla which line up in front of the terminal sulcus on the dorsum of 
the tongue, and is also present in taste buds, in the serous acini of 
the von Ebner gland, and in the duct (Figure 4). There was ACE2 ex-
pression in the blood vessels in the intrinsic lingual muscle but not in 
the connective tissue of the lamina propria. The expression of both 
ACE2 and TMPRSS22 was present in the mucous acini of the pos-
terior lingual gland where the duct also expressed both molecules 
(Figure 5). The ACE2 expression was absent in the lingual muscle 
but weakly positive in the blood vessels of the lamina propria. The 
TMPRSS2 expression was absent in the lingual muscle but present in 
the perimysium and the lamina propria.
3.3  |  Immunostaining of the normal human tissue
The expression of both ACE2 and TMPRSS2 was observed on the 
keratinized stratified squamous epithelia in the paraffin-embed-
ded sections (Figure 6). No reactions of antibodies for ACE2 and 
TMPRSS2 were observed in the nuclei and keratin layer (stratum 
corneum) except for a cross reaction with the broken or overlapped 
surface of tissue. It was found that ACE2 is expressed in the cyto-
plasm and on the cell membrane mainly in the stratum granulosum of 
the epithelia while TMPRSS2 is strongly expressed on the cell mem-
brane mainly in the stratum granulosum and stratum spinosum, but 
not in the stratum basale. In the lingual mucosa the expression of 
F I G U R E  6  Immunostaining for ACE2 and TMPRSS2 in the paraffin-embedded normal epithelia. ACE2 (upper panels) and TMPRSS2 
(lower panels). Reactions with anti-ACE2 and anti-TMPRSS2 are observed on the keratinized stratified squamous epithelia of human tongue. 
Reaction with anti-ACE is observed in the cytoplasm and on the cell membrane mainly in the stratum granulosum of epithelia (arrowheads). 
Strong reactions with anti-TMPRSS2 are observed on the cell membrane mainly in the stratum granulosum and stratum spinosum 
(arrowheads), but not in the stratum basale (SB). These reactions are not observed in the nuclei and keratin layers (KL) except for the cross 
reaction to broken or overlapped parts of the surface. Bar: 100 μm
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both ACE2 and TMPRSS2 was observed in the keratinized stratified 
squamous epithelia (Figure 7). The expression of ACE2 was present 
in the cytoplasm and on the cell membrane, and very weakly in the 
lamina propria. The expression of TMPRSS2 was present on the cell 
membrane but not in the stratum basale or in the lamina propria. 
In the buccal mucosa the expression of both ACE2 and TMPRSS2 
was observed on the non-keratinized stratified squamous epithelia 
(Figure 8). The expression of ACE was observed in the cytoplasm 
or on the cell membrane while the expression of TMPRSS2 was ob-
served on the cell membrane. There was a very weak expression 
of ACE2 in the lamina propria. The TMPRSS2 was not expressed in 
the stratum basale or in the lamina propria. In the labial mucosa the 
expression of both ACE2 and TMPRSS2 was observed on the non-
keratinized stratified squamous epithelia (Figure 9). The expression 
of ACE was observed in the cytoplasm and on the cell membrane 
while the expression of TMPRSS2 was observed on the cell mem-
brane. There was a very weak expression of ACE2 in the lamina 
propria. The TMPRSS2 was not expressed in the stratum basale or 
in the lamina propria. In the labial gland the expression of both the 
ACE2 and TMPRSS2 was observed in the mucous and serous acini 
(Figure 10). The expression of TMPRSS2 was stronger in the serous 
acini than in the mucous acini. In the striated ducts the ACE2 was 
positive but the TMPRSS2 was negative.
4  |  DISCUSSION
4.1  |  Gene expression of ACE2 and TMPRSS2 in 
mouse organs, human oral tissue, and cancer cell lines
It was shown that ACE2 and TMPRSS2 gene-expressing cells are 
present in the mouse submandibular gland and tongue as well as 
in the small intestine and kidneys (Figure 1). The gene expression 
of ACE2 in the small intestine and TMPRSS2 in the kidneys was 
significantly stronger than other tissues. These findings make it 
plausible that the results of the immunostaining can be considered 
reliable. Elsewhere, there has also been a report of ACE2 expres-
sion in an oral cancer cell line (Hinsley et al., 2017). The highest 
ACE2 levels were observed in the primary cultured normal oral 
keratinocytes, with lower levels observed in the head and neck 
squamous cell carcinoma cell lines SCC4, H357, and Cal27, and 
ACE2 was not detected in primary cultured normal oral fibroblasts 
F I G U R E  7  Immunostaining for ACE2 and TMPRSS2 of normal human lingual mucosa. Immunostaining for ACE2 (top right panel, red) and 
TMPRSS2 (right bottom panel, red) with hematoxylin staining of nuclei (blue). The expression of both ACE2 and TMPRSS2 is observed on 
the keratinized stratified squamous epithelia (asterisk). The reaction with anti-ACE is observed in the cytoplasm and on the cell membranes 
while the reaction with anti-TMPRSS2 is observed on the cell membranes (arrowheads). There is a very weak reaction with anti-ACE2 in 
the lamina propria (LP). TMPRSS2 is not expressed in the stratum basale (arrows) or in the lamina propria. Bar: 100 μm
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(Hinsley et al., 2017). There have also been reports of TMPRSS2 
expression in oral cancer and the cell lines (Cheong et al., 2009; 
Chodroff et al., 2016). Since the ACE2 gene expression in the 
tongue squamous cell carcinoma cell line HSC3 and the TMPRSS2 
gene expression in the human glioma cell line LN319 were estab-
lished by a microarray, HSC3 and LN319 were used as experimen-
tal controls of the RT-PCR analysis for the ACE2 and TMPRSS2 
gene expression in the human tissue specimens. The ACE2 gene 
expression was not established in HSC2 or HSC4 by RT-PCR 
while it was established in HSC3. The TMPRSS2 gene expression 
was not established in HSC2 or HSC3 while it was established in 
HSC4 (Figure 2). It may be postulated that the ability to express 
ACE2 and TMPRSS2 genes has been deleted in the oral cancer 
cell lines. The ACE2 and TMPRSS2 mRNAs were detected in both 
the normal human lingual mucosa collected by excision and the 
buccal mucous cells collected by grinding with a swab, and the 
gene expression of both ACE2 and TMPRSS2 was stronger in the 
lingual and buccal mucosa than in cell line controls, indicating that 
oral mucous epithelial cells express ACE2 and TMPRSS2 genes, in 
agreement with previous studies (Cheong et al., 2009; Chodroff 
et al., 2016; Hinsley et al., 2017).
4.2  |  The expressions of ACE2 and TMPRSS2 
proteins in the mouse tissue
Immunohistochemical investigations of the expression of ACE2 pro-
tein showed it to be clearly identified in small and large arteries, type 
II alveolar cells, the stratified squamous epithelium of the esophagus, 
in the monolayered columnar epithelium of the small intestine, and 
in the brush border and cytoplasm of proximal tubular cells of the 
kidneys (Hamming et al., 2004). An immunohistochemical overview 
of the ACE2 expression at low magnification has also been reported 
for the oral epithelia (Hamming et al., 2004). In this study the reac-
tion of anti-ACE2 in the kidneys was confirmed only in the proximal 
tubules but not in any other region including the glomeruli, and the 
distal tubules reacted with anti-ACE2 suggesting that this antibody 
is useful for the immunohistochemical investigation of ACE2 expres-
sion (Figure 3). The TMPRSS2 is a type II transmembrane-bound ser-
ine protease highly localized in the prostate and overexpressed in 
neoplastic prostate epithelium (Vaarala et al., 2001). The TMPRSS2 
was originally reported to be a small intestine associated protease 
(Paoloni-Giacobino et al., 1997) and was found to be present in vas-
cular endothelial cells (Aimes et al., 2003), and the gene expression 
F I G U R E  8  Immunostaining for ACE2 and TMPRSS2 of normal human buccal mucosa. HE staining (left panels) and immunostaining (right 
panels) for ACE2 (top right panel, red) and TMPRSS2 (bottom right panel, red) with DAPI staining of nuclei (blue). The expression of both 
ACE2 and TMPRSS2 is observed on the non-keratinized stratified squamous epithelia (asterisk). Reaction with anti-ACE is observed in the 
cytoplasm and on the cell membrane while reaction with anti-TMPRSS2 is observed on the cell membrane (arrowheads). There is a very 
weak reaction with anti-ACE2 in the lamina propria (LP). TMPRSS2 is not expressed in the stratum basale (arrows) or in the lamina propria. 
Bar: 100 μm
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of TMPRSS2 has been investigated in adult mouse and human tis-
sue (Vaarala et al., 2001). Human TMPRSS2 has been detected in 
the prostate, colon, stomach, and salivary glands by northern blot 
analysis and in situ hybridization analyses of mouse adult tissue has 
established that TMPRSS2 was expressed in the epithelia of the gas-
trointestinal, urogenital, and respiratory tracts (Vaarala et al., 2001). 
In this study the reaction of anti-TMPRSS2 in the small intestine was 
confirmed only in monolayered columnar epithelial cells but in no 
other region including the lamina propria mucosae did it react with 
anti-TMPRSS2, suggesting that this antibody is useful for the immu-
nohistochemical investigation of the TMPRSS2 expression (Figure 3).
In the mouse tongue the expression of both ACE2 and TMPRSS2 
was observed on the circumvallate papilla, in taste buds, in the se-
rous acini of the von Ebner gland under the taste buds, and in ducts 
(Figure 4). The expression of both ACE2 and TMPRSS22 was also 
observed on the mucous acini of the posterior lingual gland where 
the ducts also express both molecules (Figure 5). Since the reaction 
to nuclei was also observed despite blocking, it appears that the an-
tibodies have inherent affinities to nuclear proteins of the mouse 
oral tissue different from the kidneys and intestines (Figure 3), and 
are also different from human tissue (Figure 6). Overall, this suggests 
that the expression of ACE2 and TMPRSS2 is commonly present 
in vertebrate oral mucosa and salivary gland epithelial cells. It is 
thought that the taste disorders in the early stages of SARS-CoV-2 
infection may be involved in the ACE2 and TMPRSS22 expression 
in the taste buds and Ebner gland (Cevik et al., 2020; Zhang et al., 
2020a, 2020b). There is ACE2 expression in blood vessels as also 
reported elsewhere (Bertram et al., 2012) but not in the mucous lam-
ina propria. As there was reaction with anti-TMPRSS2 in the mucous 
lamina propria in the mouse oral tissue but not in the mouse small 
intestine (Figure 4), the TMPRSS2 protein distribution in the connec-
tive tissue may be different in mouse organs.
4.3  |  The expression of ACE2 and TMPRSS2 
proteins in human oral tissue
The expression of ACE2 and TMPRSS2 was investigated on paraf-
fin-embedded tongue specimens. The expression of both ACE2 and 
TMPRSS2 were confirmed in all subjects (Figure 6). The reactions 
of antibodies for ACE2 and TMPRSS2 to the oral epithelia were 
observed in the cytoplasm and on the cell membrane, but not in 
F I G U R E  9  Immunostaining for ACE2 and TMPRSS2 of normal human labial mucosa. HE staining (left panels) and immunostaining (right 
panels) for ACE2 (top right panel, red) and TMPRSS2 (bottom right panel, red) with DAPI staining of nuclei (blue). The expression of both 
ACE2 and TMPRSS2 is observed on the non-keratinized stratified squamous epithelia (asterisk). The reaction with anti-ACE is observed in 
the cytoplasm and on the cell membrane while the reaction with anti-TMPRSS2 is observed on the cell membrane (arrowheads). There is 
a very weak reaction with anti-ACE2 in the lamina propria (LP). TMPRSS2 is not expressed in the stratum basale (arrows) or in the lamina 
propria. Bar: 100 μm
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nuclei and keratin layers, indicating that the antibodies for ACE2 
and TMPRSS2 used in this study are useful in the investigation of 
paraffin-embedded specimens. It was found that the stratum granu-
losum expresses both ACE2 and TMPRSS2 on the cell membrane, 
suggesting that SARS-CoV-2 is able to infect human oral keratinized 
stratified squamous epithelia via wounding or microlaceration like 
papillomavirus (Syrjänen, 2018). Since the expression of ACE2 and 
TMPRSS2 is rarely or not observed in stratum basale, it is thought 
that the production of ACE2 and TMPRSS2 is controlled in the dif-
ferentiation and movement of basal cells to the mucous surface.
In the lingual mucosa of the normal fresh sample, the ex-
pression of both ACE2 and TMPRSS2 was observed on both the 
keratinized stratified squamous epithelia of the tongue and the 
non-keratinized stratified squamous epithelia of the lip and cheek 
in the same staining pattern among the tissues (Figures 6–8). 
There were differences in the expression patterns of the ACE2 
and TMPRSS2 in cells. The ACE2 was present in the cytoplasm 
and on the cell membrane, and very weakly in the lamina pro-
pria, while the TMPRSS2 was present on the cell membrane but 
not in the stratum basale and in the lamina propria (Figures 6–8). 
Considering this result of the ACE2 and TMPRSS2 gene expres-
sion in the lingual and buccal mucosa by tissue PCR and recent 
studies for the oral ACE2 taken together, these suggest that the 
expression of the ACE2 and TMPRSS2 proteins in the human oral 
epithelia may be assumed to be general. There is no observation 
of these proteins in the human taste buds in this study, and the 
taste disorders in the early stages of SARS-CoV-2 infection may be 
involved in the ACE2 and TMPRSS22 expression in the taste buds 
and Ebner gland (Cevik et al., 2020; Zhang et al., 2020a, 2020b). 
Since the tissue mRNA extraction by a swab was successful at the 
same level as the excision, it is thought that sampling by grinding 
with a swab to the buccal mucosa is effective for the PCR test of 
the SARS-CoV-2 infection. In the labial gland, the expression of 
both ACE2 and TMPRSS2 was observed in the mucous and se-
rous acini (Figure 9). The expression of TMPRSS2 was stronger in 
the serous acini than in the mucous acini. In the striated ducts 
the ACE2 was also positive while the TMPRSS2 was negative. This 
may suggest that SARS-CoV-2 attaches to the oral mucosa and the 
orifice of the ducts of salivary glands, and also in the minor sali-
vary glands which are present under all of the oral mucosa.
Among seven types of coronavirus that can infect humans, 
four types account for 15% of the cause of colds and three types 
are SARS-CoV identified in 2002, MERS-CoV in 2012, and new 
SARS-CoV-2 (Zhang et al., 2020a, 2020b). The SARS-CoV-2 is a 
F I G U R E  1 0  Immunostaining for ACE2 and TMPRSS2 of the labial gland. HE staining (left panels) and immunostaining (right panels) for 
ACE2 (right upper panel, red) and TMPRSS2 (bottom right panel, red) with DAPI staining of nuclei (blue). The expression of both ACE2 and 
TMPRSS2 is observed in the mucous acini (arrows, MA) and serous acini (arrows, SA). The expression of TMPRSS2 is stronger in serous acini 
(arrows, SA) than in mucous acini (arrows, MA). In the striated ducts (SD, arrowheads), the ACE2 is positive but the TMPRSS2 is negative. 
Bar: 100 μm
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positive-sense single-stranded RNA virus and consists of envelope 
protein, matrix protein, nucleoprotein, and spike protein which binds 
to ACE2 with high affinity (Wrapp et al., 2020). The SARS-CoV-2 
binds to ACE2 and the cell surface protease TMPRSS2 cleaves 
the SARS-CoV-2 spike protein, causing the virus to invade the cell 
(Hoffmann et al., 2020). The upper airway, lungs, and intestinal epi-
thelial cells are expressing ACE2 and TMPRSS, particularly the nasal 
mucosal epithelial cells strongly express these (Sungnak et al., 2020). 
Patients with SARS-CoV-2 infections develop pharyngitis and runny 
nose, and excrete virions from the upper airway. When taking pre-
ventive measures against the SARS-CoV-2 infection, the fact that 
SARS-CoV-2 can infect not only the respiratory system but also the 
digestive tract should be taken into consideration because SARS-
CoV-2 has been identified in feces (Wang et al., 2020). Furthermore, 
SARS-CoV-2 is excreted from the nasal cavity and pharynx even in 
the asymptomatic stage and is able to infect other hosts (Arons et al., 
2020). It may be important from a public health point of view that 
ACE2 and TMPRSS2 which the virus can attach to are usually ex-
pressed in the oral cavity as the viral shedding route.
5  |  CONCLUSIONS
The results may suggest that the oral cavity can be considered an 
important organ for the SARS-CoV-2 attachment before infect-
ing the respiratory tract, lungs, and intestines, and may provide a 
preventive medical avenue against COVID-19. This would make it 
possible to hypothesize that facemasks are very effective in con-
trolling COVID-19 infection by preventing saliva from scattering 
and sealing in infected persons as well as the skin and clothes, 
an issue which attention is presently focused on. It is known that 
sodium lauryl sulfate, an anionic surfactant with protein dena-
turing potency, is a potent inhibitor of the infectivity of several 
enveloped viruses through a denaturation of the viral envelope 
(Piret et al., 2002). Mouthwash containing sodium lauryl sulfate 
may be effective in preventing SARS-CoV-2 infection through the 
oral cavity.
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